AdultPediatricCOVID-19 Disease Prevention June 2023: FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended the 2023-2024 composition be updated to a monovalent COVID-19 vaccine with an XBB-lineage of the Omicron variant (ie, XBB.1.5) April 2023: Adults and children as young as 6 months of age may be eligible for an updated bivalent COVID-19 vaccine from either Moderna or Pfizer for all doses Original (wild-type) monovalent COVID-19 mRNA vaccines that wer first available in the United States are no longer authorized COVID-19 Disease Prevention June 2023: FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended the 2023-2024 composition be updated to a monovalent COVID-19 vaccine with an XBB-lineage of the Omicron variant (ie, XBB.1.5) April 2023: Adults and children as young as 6 months of age may be eligible for an updated bivalent COVID-19 vaccine from either Moderna or Pfizer for all doses Original (wild-type) monovalent COVID-19 mRNA vaccines that wer first available in the United States are no longer authorized No images available for this drug. No images available for this drug.A Patient Handout is not currently available for this monograph.Print